GLYC
GlycoMimetics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website glycomimetics.com
- Employees(FY) 38
- ISIN US38000Q1022
Performance
+0.47%
1W
-86.07%
1M
-90.7%
3M
-77.66%
6M
-87.31%
YTD
-85.32%
1Y
Profile
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and inflammatory diseases with unmet needs in the United States. It is developing uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat AML, as well as in phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and galectin-3 antagonists, a carbohydrate-binding protein. In addition, it is developing GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of cancers that affect the bone and bone marrow, including solid tumors. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.
Technical Analysis of GLYC 2024-05-10
Overview:
In analyzing the technical indicators for GLYC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Indicators:
- Moving Averages (MA): The 5-day MA has been consistently decreasing, indicating a d...
Recent News & Updates
- 2024-05-09 10:58
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024(Investorplace)
- 2024-05-09 07:19
GlycoMimetics: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-07 19:42
- 2024-05-06 17:21
- 2024-05-06 03:53
- 2024-05-06 00:45
- 2024-05-05 20:40
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?(Investorplace)
- 2024-05-05 19:52
- 2024-05-05 19:28
- 2024-05-05 18:00
- 2024-04-24 19:00
- 2024-03-27 22:12
- 2024-03-27 14:10
Q4 2023 GlycoMimetics Inc Earnings Call(Yahoo Finance)
- 2024-03-26 23:53
GLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023(Investorplace)
- 2024-03-26 22:31
- 2024-03-26 19:14
GlycoMimetics: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-26 19:00
- 2024-03-20 20:50
- 2024-03-12 19:00
- 2024-02-25 18:00
- 2024-02-11 18:00
- 2024-01-03 18:00
- 2024-01-02 18:00
- 2023-12-09 23:00
- 2023-11-08 18:00
- 2023-11-04 20:51
- 2023-11-03 13:48
Q3 2023 GlycoMimetics Inc Earnings Call(Yahoo Finance)
- 2023-11-02 22:33
GlycoMimetics Inc (GLYC) Reports Q3 2023 Financial Results(Yahoo Finance)
- 2023-11-02 19:07
GlycoMimetics: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-02 19:00
Page 1 of 4
previousnext